UJI AKTIVITAS ANTIOKSIDAN DARI AMPAS HASIL PENGOLAHAN SAGU (Metroxylon sagu Rottb)
PHARMACON · 01.08.2013 · 2 (3)
DOI: 10.35799/pha.2.2013.2373 ↗Kurz gefasst
Fachartikel in der Zeitschrift PHARMACON, online erschienen am 01.08.2013. Verfasst von Selvian Talapessy und 2 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
ABSTRACTThe study aimed to determine the phenolic content and antioxidant activity of sago wasteprocessing results. Results of processing sago pulp esxtraction was conducted using 1 x 24hour maceration using solvents ethanol with a concentration of 20, 40, 60 and 80%. Phenoliccontent was determined by Folin Ciocalteu method and determination of antioxidant activityusing the DPPH free radical scavengers. The results showed that the extract with the solventconcentration of 40% has a higher total phenolic 83,26 μg/mL followed by solvent extractconcentration of 20, 60 and 80% respectively 70,01; 60,58; 22,04 μg/mL. extract with 60%solvent concentration has free radical scavengers activity the highest of 82,75% followed byconcentration of solvent extracts 80, 20 and 60% are respectively 80,45; 76,62; 62,83%.These results suggest that the processing of sago pulp extract contains phenolic antioxidantsand can be potentially as.Keywords : pulp extract sago precessing results, phenolic compend, antioxidants.
Zitieren
APA
Talapessy, S., Suryanto, E., & Yudistira, A. (2013). UJI AKTIVITAS ANTIOKSIDAN DARI AMPAS HASIL PENGOLAHAN SAGU (Metroxylon sagu Rottb). PHARMACON, 2(3). https://doi.org/10.35799/pha.2.2013.2373
Vancouver
Talapessy S, Suryanto E, Yudistira A. UJI AKTIVITAS ANTIOKSIDAN DARI AMPAS HASIL PENGOLAHAN SAGU (Metroxylon sagu Rottb). PHARMACON. 2013;2(3). doi:10.35799/pha.2.2013.2373
BibTeX
@article{Talapessy2013,
author = {Talapessy, Selvian and Suryanto, Edi and Yudistira, Adithya},
title = {UJI AKTIVITAS ANTIOKSIDAN DARI AMPAS HASIL PENGOLAHAN SAGU (Metroxylon sagu Rottb)},
journal = {PHARMACON},
year = {2013},
volume = {2},
number = {3},
doi = {10.35799/pha.2.2013.2373}
}
EUVIMED